Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis
Go back to Enlivex Announces Issuance of Australian Patent Covering the Use of Allocetra™ in Patients with Osteoarthritis| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 0.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $0.94 | |||
| Open | $0.62 | 52 Week Low | $0.47 | |||
| Day High | $0.62 | P/E | N/A | |||
| Day Low | $0.62 | EPS | $-0.11 | |||
| Volume | 32 | |||||
| Enliven Marketing Technologies Corporation (NASDAQ: ENLV) | Delayed: 0.62 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.62 | 52 Week High | $0.94 | |||
| Open | $0.62 | 52 Week Low | $0.47 | |||
| Day High | $0.62 | P/E | N/A | |||
| Day Low | $0.62 | EPS | $-0.11 | |||
| Volume | 32 | |||||
